BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28622441)

  • 21. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
    Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
    Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
    Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States.
    Doycheva I; Issa D; Watt KD; Lopez R; Rifai G; Alkhouri N
    J Clin Gastroenterol; 2018 Apr; 52(4):339-346. PubMed ID: 28961576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality and Cardiovascular Outcomes in Adult Non-Liver Solid Organ Transplant Patients With Nonalcoholic Steatohepatitis.
    Dutta N; Marka N; Lake J; Lim N
    Transplant Proc; 2023 Nov; 55(9):2023-2026. PubMed ID: 37730450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI.
    Lee DU; Bahadur A; Ponder R; Lee KJ; Fan GH; Chou H; Lominadze Z
    Hepatol Int; 2023 Dec; 17(6):1393-1415. PubMed ID: 37160862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Yuan L; Hanlon CL; Terrault N; Alqahtani S; Tamim H; Lai M; Saberi B
    Am J Gastroenterol; 2022 Mar; 117(3):433-444. PubMed ID: 35083985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis.
    Wang X; Li J; Riaz DR; Shi G; Liu C; Dai Y
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):394-402.e1. PubMed ID: 24076414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis.
    Dimou FM; Mehta HB; Adhikari D; Harland RC; Riall TS; Kuo YF
    Surgery; 2016 Dec; 160(6):1533-1543. PubMed ID: 27554622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
    McCabe P; Galoosian A; Wong RJ
    Dig Dis Sci; 2020 May; 65(5):1501-1511. PubMed ID: 31642005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox.
    Satapathy SK; Jiang Y; Agbim U; Wu C; Bernstein DE; Teperman LW; Kedia SK; Aithal GP; Bhamidimarri KR; Duseja A; Maiwall R; Maliakkal B; Jalal P; Patel K; Puri P; Ravinuthala R; Wong VW; Abdelmalek MF; Ahmed A; Thuluvath PJ; Singal AK;
    Liver Transpl; 2020 Jan; 26(1):68-79. PubMed ID: 31665561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis.
    Loy VM; Joyce C; Bello S; VonRoenn N; Cotler SJ
    Clin Transplant; 2018 Aug; 32(8):e13297. PubMed ID: 29804305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
    Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
    Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
    Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
    Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.